An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment
NCT00131612
·
clinicaltrials.gov ↗
TERMINATED
Status
120
Enrollment
OTHER
Sponsor class
Stopped
did not apply for ethics renewal
Conditions
Breast Cancer
Interventions
DRUG:
FEC 100
Sponsor
AHS Cancer Control Alberta